Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Interest & Investment Income for 10 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 16.22% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2025, up 3.96% year-over-year, with the annual reading at $15.3 million for FY2025, 3.96% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $4.1 million at Rhythm Pharmaceuticals, down from $4.3 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $4.3 million in Q3 2025, with the low at $21000.0 in Q2 2021.
  • Average Interest & Investment Income over 5 years is $2.4 million, with a median of $3.2 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income plummeted 97.38% in 2021, then soared 2169.4% in 2022.
  • Over 5 years, Interest & Investment Income stood at $134000.0 in 2021, then skyrocketed by 2169.4% to $3.0 million in 2022, then grew by 25.58% to $3.8 million in 2023, then dropped by 7.96% to $3.5 million in 2024, then rose by 16.22% to $4.1 million in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $4.1 million, $4.3 million, and $3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.